Fosfomycin resistance in Escherichia coli, Pennsylvania, USA

Emerging Infectious Diseases

Volumn 21, Issue 11, 2015, Pages 2045-2047

  Alrowais, Hind ^a   McElheny, Christi L ^a   Spychala, Caressa N ^a   Sastry, Sangeeta ^a   Guo, Qinglan ^a,b,c   Butt, Adeel A ^a,d,e   Doi, Yohei ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b FUDAN UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

^d Hamad Healthcare Quality Institute   (Qatar)

^e HAMAD MEDICAL CORPORATION   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFAZOLIN; CEFTRIAXONE; CIPROFLOXACIN; FOSFOMYCIN; MOXIFLOXACIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BLACTX M 65 GENE; CASE REPORT; END STAGE RENAL DISEASE; ESCHERICHIA COLI; FEMALE; FOSA3 GENE; GENE SEQUENCE; HOSPITALIZATION; HUMAN; NUCLEOTIDE SEQUENCE; PERITONEAL CATHETER; PERITONEAL DIALYSIS; POLYMERASE CHAIN REACTION; RMTB GENE; UNITED STATES; URINARY TRACT INFECTION; DNA SEQUENCE; ESCHERICHIA COLI INFECTIONS; GENETICS; IMMUNOLOGY; PENNSYLVANIA; UTILIZATION;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FOSFOMYCIN; HUMANS; PENNSYLVANIA; SEQUENCE ANALYSIS, DNA;

EID: 84944569105     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2111.150750     Document Type: Article

References (14)

1. Johnson JR, Drawz SM, Porter S, Kuskowski MA. Susceptibility to alternative oral antimicrobial agents in relation to sequence type ST131 status and coresistance phenotype among recent Escherichia coli isolates from U.S. veterans. Antimicrob Agents Chemother. 2013;57:4856-60. http://dx.doi.org/10.1128/AAC.00650-13
2. Castañeda-García A, Blázquez J, Rodríguez-Rojas A. Molecular mechanisms and clinical impact of acquired and intrinsic fosfomycin resistance. Antibiotics. 2013;2:217-36. http://dx.doi.org/10.3390/antibiotics2020217
3. Wachino J, Yamane K, Suzuki S, Kimura K, Arakawa Y. Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes. Antimicrob Agents Chemother. 2010;54:3061-4. http://dx.doi.org/10.1128/AAC.01834-09
4. Doi Y, Adams-Haduch JM, Paterson DL. Escherichia coli isolate coproducing 16S rRNA nethylase and CTX-M-type extended-spectrum β-lactamase isolated from an outpatient in the United States. Antimicrob Agents Chemother. 2008;52:1204-5. http://dx.doi.org/10.1128/AAC.01320-07
5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement M100-S24. Wayne (PA): The Institute; 2014.
6. Lee SY, Park YJ, Yu JK, Jung S, Kim Y, Jeong SH, et al. Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3. J Antimicrob Chemother. 2012;67:2843-7. http://dx.doi.org/10.1093/jac/dks319
7. Hou J, Huang X, Deng Y, He L, Yang T, Zeng Z, et al. Dissemination of the fosfomycin resistance gene fosA3 with CTX-M β-lactamase genes and rmtB carried on IncFII plasmids among Escherichia coli isolates from pets in China. Antimicrob Agents Chemother. 2012;56:2135-8. http://dx.doi.org/10.1128/AAC.05104-11
8. Li JJ, Lee CS, Sheng JF, Doi Y. Complete sequence of a conjugative IncN plasmid harboring blaKPC-2, blaSHV-12, and qnrS1 from an Escherichia coli sequence type 648 strain. Antimicrob Agents Chemother. 2014;58:6974-7. http://dx.doi.org/10.1128/AAC.03632-14
9. Villa L, Garcia-Fernandez A, Fortini D, Carattoli A. Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J Antimicrob Chemother. 2010;65:2518-29. http://dx.doi.org/10.1093/jac/dkq347
10. Sun H, Li S, Xie Z, Yang F, Sun Y, Zhu Y, et al. A novel multidrug resistance plasmid isolated from an Escherichia coli strain resistant to aminoglycosides. J Antimicrob Chemother. 2012;67:1635-8. http://dx.doi.org/10.1093/jac/dks107
11. He L, Partridge SR, Yang X, Hou J, Deng Y, Yao Q, et al. Complete nucleotide sequence of pHN7A8, an F33:A-:B- type epidemic plasmid carrying blaCTX-M-65, fosA3 and rmtB from China. J Antimicrob Chemother. 2013;68:46-50. http://dx.doi.org/10.1093/jac/dks369
12. Ho PL, Chan J, Lo WU, Law PY, Chow KH. Plasmid-mediated fosfomycin resistance in Escherichia coli isolated from pig. Vet Microbiol. 2013;162:964-7. http://dx.doi.org/10.1016/j.vetmic.2012.09.023
13. Ho PL, Chan J, Lo WU, Lai EL, Cheung YY, Lau TC, et al. Prevalence and molecular epidemiology of plasmid-mediated fosfomycin resistance genes among blood and urinary Escherichia coli isolates. J Med Microbiol. 2013;62:1707-13. http://dx.doi.org/10.1099/jmm.0.062653-0
14. Hou J, Yang X, Zeng Z, Lv L, Yang T, Lin D, et al. Detection of the plasmid-encoded fosfomycin resistance gene fosA3 in Escherichia coli of food-animal origin. J Antimicrob Chemother. 2013;68:766-70. http://dx.doi.org/10.1093/jac/dks465